logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Mei Pharma, Inc.


USPTO Granted Patents = 33



Trademarks = 1

Forward Citations = 173

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Eric T Sun (9 out of 19 patents)

silverMedal Ofir Moreno (8 out of 17 patents)

bronzeMedal Andrew Heaton (7 out of 19 patents)

4.  S David Brown (6 out of 14 patents)

5.  David J Matthews (6 out of 23 patents)

6.  DiZhong Chen (6 out of 11 patents)

7.  Hong Yan Song (6 out of 8 patents)

8.  Niefang Yu (6 out of 8 patents)

9.  Yong Colin Zou (6 out of 33 patents)

10.  Daniel P Gold (4 out of 10 patents)

11.  Alan James Husband (4 out of 13 patents)

12.  George Jeoffreys (3 out of 4 patents)

13.  Alison Johnson (3 out of 4 patents)

14.  Haishan Wang (3 out of 7 patents)

15.  Ken Chi Lik Lee (3 out of 3 patents)


33 patents:

1. 12421216 - Voruciclib polymorphs and methods of making and using thereof (2025-09-23),
2. 12161644 - Combination therapy (2024-12-10),
3. 12059422 - (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases (2024-08-13),
4. 11723893 - Isoflavonoid compositions and methods for the treatment of cancer (2023-08-15),
5. 11583514 - Isoflavonoid compounds and methods for the treatment of cancer (2023-02-21),
6. 11400097 - (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases (2022-08-02),
7. 11351176 - Combination therapy (2022-06-07),
8. 11304953 - Combination therapy (2022-04-19),
9. 10980774 - Combination therapies (2021-04-20),
10. 10973799 - Isoflavonoid compositions and methods for the treatment of cancer (2021-04-13),
11. 10736881 - Benzimidazole derivatives: preparation and pharmaceutical applications (2020-08-11),
12. 10626092 - Polymorphic forms of 3-[(2-butyl-1-(2-diethylamino-ethyl)-1H-benzoimidazol-5-yl]-N-hydroxy-acrylamide and uses thereof (2020-04-21),
13. 10603324 - (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases (2020-03-31),
14. 10369132 - Isoflavonoid compositions and methods for the treatment of cancer (2019-08-06),
15. 10335415 - (Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases (2019-07-02),
MEI Pharma, Inc. is a San Diego-based pharmaceutical company focused on the discovery and development of novel therapies for cancer. Through its research and development efforts, MEI Pharma aims to bring innovative treatments to patients with unmet medical needs. The company's pipeline includes potential drug candidates targeting various cancer indications, such as acute leukemia, lymphomas, and solid tumors. MEI Pharma's dedication to advancing cancer therapeutics has positioned them as a leader in the field.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
33 Patents

#184 in San Diego, CA

#2,382 in California

#9,948 in US

#19,556 in the World

...
San Diego, CA, United States of America

Mei Pharma, Inc.

Forward Citations = 173

17 inventors:

goldMedal Eric T Sun (9 out of 19 patents)

silverMedal Ofir Moreno (8 out of 17 patents)

bronzeMedal Andrew Heaton (7 out of 19 patents)

4.  S David Brown (6 out of 14 patents)

5.  David J Matthews (6 out of 23 patents)

Please report any incorrect information to support@idiyas.com
Loading…